Advances in Nuclear Cardiology: Instrumentation, Software and Radiopharmaceuticals
Journal Title: Nükleer Tıp Seminerleri - Year 2018, Vol 4, Issue 2
Abstract
Progress in equipment and software technology in nuclear medicine has contributed substantially to cardiac imaging. The most notable consequences of this progress are improvement in image quality and reduction in acquisition time and radiation dose. Introduction of new pharmaceuticals in parallel with the progress in equipment technology has enabled imaging of important molecular processes. This review summarizes the recent progress in equipment, software, and radiopharmaceuticals utilised in nuclear cardiac imaging and their contribution to diagnosis of cardiac disease.
Authors and Affiliations
Elif Özdemir, Deniz Bedel
Theranostics Applications in Neuroendocrine Tumors of Thorax
The term of theranostic refers to the combination of therapy and diagnostic imaging. In practise, this concept has dated back about 50 years ago, however, the most successful example of theranostic approaches has emerged...
Systemic Therapy in Metastatic Castration-Resistant Prostate Cancer
Prostate cancer is the second leading cause of cancer death in men. Tumor growth and progression are androgen-dependent; for this reason, androgen deprivation therapy has been the main therapeutic intervention for treatm...
Sentinel Lymph Node Biopsy: Actual Approaches
Sentinel lymph node biopsy has entered the clinical routine in the nodal status assessment of early-stage cancers. The method has different application techniques and limitations according to the localization of the prim...
Advances in Nuclear Cardiology: Instrumentation, Software and Radiopharmaceuticals
Progress in equipment and software technology in nuclear medicine has contributed substantially to cardiac imaging. The most notable consequences of this progress are improvement in image quality and reduction in acquisi...
Treatment Approaches in Lung Cancer
Lung cancer is the leading cause of cancer death in both men and women worldwide, accounting for 1.8 million new cases and 1.6 million deaths annually. Although most lung cancers are still diagnosed at a late stage, ther...